Effusanin B Inhibits Lung Cancer by Prompting Apoptosis and Inhibiting Angiogenesis
Molecules · 2023
DOI: 10.3390/molecules28237682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Jiantong Hou und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Molecular Drug Research, and College of Pharmacy, Nankai University, Ti…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, Hainan Normal University.
Abstract (Originalsprache)
Cancer is one of the deadliest human diseases, causing high rates of illness and death. Lung cancer has the highest mortality rate among all malignancies worldwide. Effusanin B, a diterpenoid derived from Isodon serra, showed therapeutic potential in treating non-small-cell lung cancer (NSCLC). Further research on the mechanism indicated that effusanin B inhibited the proliferation and migration of A549 cells both in vivo and in vitro. The in vitro activity assay demonstrated that effusanin B exhibited significant anticancer activity. Effusanin B induced apoptosis, promoted cell cycle arrest, increased the production of reactive oxygen species (ROS), and altered the mitochondrial membrane potential (MMP). Based on mechanistic studies, effusanin B was found to inhibit the proliferation and migration of A549 cells by affecting the signal transducer and activator of transcription 3 (STAT3) and focal adhesion kinase (FAK) pathways. Moreover, effusanin B inhibited tumor growth and spread in a zebrafish xenograft model and demonstrated anti-angiogenic effects in a transgenic zebrafish model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Molecular Drug Research, and College of Pharmacy, Nankai University, Tianjin 300350, China.
- Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, Hainan Normal University, Haikou 571158, China.
Förderung
- National Natural Science Foundation of China
- Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, Hainan Normal University
Zitieren
APA
Hou, J., Li, Y., Xing, H., Cao, R., Jin, X., Xu, J., & Guo, Y. (2023). Effusanin B Inhibits Lung Cancer by Prompting Apoptosis and Inhibiting Angiogenesis. Molecules. https://doi.org/10.3390/molecules28237682
Vancouver
Hou J, Li Y, Xing H, Cao R, Jin X, Xu J, et al. Effusanin B Inhibits Lung Cancer by Prompting Apoptosis and Inhibiting Angiogenesis. Molecules. 2023. doi:10.3390/molecules28237682
BibTeX
@article{Hou2023,
author = {Hou, Jiantong and Li, Ying and Xing, Honghong and Cao, Ruyu and Jin, Xiaomeng and Xu, Jing and Guo, Yuanqiang},
title = {Effusanin B Inhibits Lung Cancer by Prompting Apoptosis and Inhibiting Angiogenesis},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28237682}
}
EUVIMED